ADAM10 and Alzheimer disease: In light of these considerations, we should take into consideration non-transgenic AD mice models, For instance, interfering with synaptic ADAM10 localization/activity for 2 weeks affects APP metabolism, increasing APP amyloidogenic cleavage with a modest but significant raise of Aβ release and of low-n Aβ aggregate production (Epis et al., 2010).